Jia Jie Biomedical Co Ltd (4109) — Cash Flow-to-Debt Ratio
Jia Jie Biomedical Co Ltd (4109) has a Cash Flow-to-Debt Ratio of 0.06x as of December 2025, meaning its operating cash flow of NT$11.32 Million could theoretically repay 0% of its total liabilities (NT$174.89 Million) in one year. Explore Jia Jie Biomedical Co Ltd strategic investment ratio to see how much of total assets are deployed in long-term investments.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jia Jie Biomedical Co Ltd Cash Flow-to-Debt Ratio (2015–2025)
Historical debt coverage capacity for Jia Jie Biomedical Co Ltd across 11 annual periods. Also explore 4109 total assets for the complete picture of this company's asset base.
Annual Cash Flow-to-Debt Ratio for Jia Jie Biomedical Co Ltd (2015–2025)
Year-by-year debt coverage analysis for Jia Jie Biomedical Co Ltd. For market capitalisation and broader financial context, see how much is Jia Jie Biomedical Co Ltd worth.
| Year | CF-to-Debt Ratio | Operating CF (TWD) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.12x | NT$21.34 Million | NT$174.89 Million | ▼ -66.1% |
| 2024 | 0.36x | NT$44.35 Million | NT$123.08 Million | ▲ +2851.1% |
| 2023 | -0.01x | NT$-4.49 Million | NT$342.69 Million | ▲ +88.1% |
| 2022 | -0.11x | NT$-8.78 Million | NT$80.00 Million | ▼ -317.0% |
| 2021 | 0.05x | NT$4.37 Million | NT$86.47 Million | ▼ -84.8% |
| 2020 | 0.33x | NT$27.10 Million | NT$81.44 Million | ▲ +116.7% |
| 2019 | 0.15x | NT$24.71 Million | NT$160.92 Million | ▲ +574.2% |
| 2018 | -0.03x | NT$-13.10 Million | NT$404.40 Million | ▼ -46.6% |
| 2017 | -0.02x | NT$-13.73 Million | NT$621.58 Million | ▲ +80.2% |
| 2016 | -0.11x | NT$-76.54 Million | NT$684.91 Million | ▼ -181.0% |
| 2015 | 0.14x | NT$82.22 Million | NT$595.84 Million | — |